# | Title | Journal | Year | Citations |
---|
1 | Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles | Cancer Letters | 2004 | 1,728 |
2 | Circular RNA: A new star of noncoding RNAs | Cancer Letters | 2015 | 1,457 |
3 | Tumor microenvironment and therapeutic response | Cancer Letters | 2017 | 1,267 |
4 | Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles | Cancer Letters | 2006 | 1,251 |
5 | Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice | Cancer Letters | 2008 | 1,044 |
6 | Long non-coding RNAs: A new frontier in the study of human diseases | Cancer Letters | 2013 | 1,041 |
7 | Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury | Cancer Letters | 2012 | 1,019 |
8 | The insulin-like growth factor system and cancer | Cancer Letters | 2003 | 1,002 |
9 | Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings | Cancer Letters | 1987 | 958 |
10 | Anti-tumour and antioxidant activity of natural curcuminoids | Cancer Letters | 1995 | 956 |
11 | Curcumin and cancer: An “old-age” disease with an “age-old” solution | Cancer Letters | 2008 | 951 |
12 | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Cancer Letters | 2008 | 929 |
13 | HDAC family: What are the cancer relevant targets? | Cancer Letters | 2009 | 893 |
14 | Circulating tumor cells (CTC) detection: Clinical impact and future directions | Cancer Letters | 2007 | 863 |
15 | Anthocyanins and their role in cancer prevention | Cancer Letters | 2008 | 840 |
16 | Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC | Cancer Letters | 1995 | 793 |
17 | Chemopreventive and therapeutic effects of curcumin | Cancer Letters | 2005 | 771 |
18 | p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents | Cancer Letters | 2014 | 765 |
19 | Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy | Cancer Letters | 2020 | 753 |
20 | DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis | Cancer Letters | 2013 | 720 |
21 | Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals | Cancer Letters | 2017 | 704 |
22 | Bovine milk-derived exosomes for drug delivery | Cancer Letters | 2016 | 630 |
23 | Multitargeted cancer prevention by quercetin | Cancer Letters | 2008 | 622 |
24 | Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy | Cancer Letters | 2007 | 605 |
25 | Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer | Cancer Letters | 2017 | 603 |
26 | Tumor microenvironment: Sanctuary of the devil | Cancer Letters | 2015 | 601 |
27 | Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth | Cancer Letters | 2013 | 597 |
28 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade | Cancer Letters | 2016 | 595 |
29 | The anti-inflammatory potential of berberine in vitro and in vivo | Cancer Letters | 2004 | 593 |
30 | Helicobacter pylori-induced gastric inflammation and gastric cancer | Cancer Letters | 2014 | 580 |
31 | Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches | Cancer Letters | 2014 | 577 |
32 | The role of CXC chemokines and their receptors in cancer | Cancer Letters | 2008 | 565 |
33 | Potential anticancer activity of turmeric (Curcuma longa) | Cancer Letters | 1985 | 562 |
34 | Multi-targeted therapy of cancer by genistein | Cancer Letters | 2008 | 554 |
35 | Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy | Cancer Letters | 2008 | 548 |
36 | The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism | Cancer Letters | 2015 | 541 |
37 | Oxidative stress, DNA methylation and carcinogenesis | Cancer Letters | 2008 | 530 |
38 | Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression | Cancer Letters | 2013 | 524 |
39 | Angiopoietins in angiogenesis | Cancer Letters | 2013 | 523 |
40 | Role of aberrant crypt foci in understanding the pathogenesis of colon cancer | Cancer Letters | 1995 | 522 |
41 | Role of chemokines in tumor growth | Cancer Letters | 2007 | 516 |
42 | Anoikis resistance and tumor metastasis | Cancer Letters | 2008 | 509 |
43 | The inflammatory chemokines CCL2 and CCL5 in breast cancer | Cancer Letters | 2008 | 502 |
44 | Cancer related inflammation: The macrophage connection | Cancer Letters | 2008 | 499 |
45 | Cytochrome P450-mediated metabolism of estrogens and its regulation in human | Cancer Letters | 2005 | 488 |
46 | c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention | Cancer Letters | 2005 | 488 |
47 | Nrf2 as a novel molecular target for chemoprevention | Cancer Letters | 2005 | 476 |
48 | Role of chemopreventive agents in cancer therapy | Cancer Letters | 2004 | 463 |
49 | Multi-targeted prevention of cancer by sulforaphane | Cancer Letters | 2008 | 457 |
50 | Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene | Cancer Letters | 2009 | 456 |